Try a new search

Format these results:

Searched for:

in-biosketch:yes

person:altmal01

Total Results:

4802


Ambitious HIV plan slowed by obstacles WHO still optimistic about 2005 goal [Newspaper Article]

Altman, Lawrence K
In its first progress report, issued a day before the start of the 15th International AIDS Conference in Bangkok on Sunday, the agency said that an estimated 440,000 people were being treated. That is about twice as many as in 2002 and 60,000 less than the WHO's goal at this point, said Dr. Jim Kim, director of the agency's AIDS program. [Lee Jong Wook] has staked his prestige on the effort, saying that the United Nations agency could not afford to let 3 by 5 fail because 'the collective response to the HIV/AIDS pandemic is the benchmark by which our generation will be judged.' Critics could point to a news conference in Bangkok on Saturday, WHO officials were long on promises and less specific about data concerning the effort that the Geneva-based agency is conducting with a number of government and private groups. For example, the WHO published a table listing the estimated number of people receiving antiretroviral treatment by country for 49 key countries. The total was 327,000. The WHO did not publish the countries with the remaining 113,000, and officials did not provide a list when asked at the news conference. The WHO has said 100,000 workers will be needed to meet the 3 by 5 goal. Since 2001, only about 15,000 workers have been trained in antiretroviral therapy in 32 affected countries. At least 3,000 workers have been trained in the first half of 2004, indicating that the training is gaining momentum, the report said
PROQUEST:661643631
ISSN: 0294-8052
CID: 81957

AIDS summit starts on bad note [Newspaper Article]

Altman, Lawrence K
UNAIDS has emphasized the need to put AIDS on the agendas of political meetings such as those of the Group of 8, a coalition of the world's top industrialized nations. At the same time, [Peter Piot] and others have tried to get heads of state to attend meetings so as to combine politics and public policy with the science of AIDS
PROQUEST:661558881
ISSN: 1085-6706
CID: 81955

H.I.V. Goal Still Possible, U.N. Health Unit Says [Newspaper Article]

Altman, Lawrence K
The program, known as 3 by 5, has been a subject of debate since the agency's director general, Dr. Lee Jong Wook, announced it last fall. In its first progress report, issued a day before the 15th International AIDS Conference here on Sunday, the World Health Organization estimated that 440,000 people were being treated. That is about twice as many as in 2002, said Dr. Jim Kim, director of the agency's AIDS program. But the agency's goal had been to treat 60,000 more people by now. Only Botswana, Indonesia and Uganda have published such plans. Botswana is treating 18,000 people, with a goal of 30,000; Indonesia is treating 1,500, with a goal of 3,500; and Uganda is treating 20,000, with a goal of 55,000, said Melanie Zipperer, an agency spokeswoman
PROQUEST:661379351
ISSN: 0362-4331
CID: 81964

Drug delivery focus of AIDS program [Newspaper Article]

Altman, Lawrence K
In its first progress report, issued a day before the 15th International AIDS Conference here on Sunday, the WHO estimated that 440,000 people were being treated. That is about twice as many as in 2002, said Dr. Jim Kim, director of the agency's AIDS program. But the agency's goal had been to treat 60,000 more people by now. [Lee Jong Wook] said that the U.N. agency could not let it fail because 'the collective response to the HIV/AIDS pandemic is the benchmark by which our generation will be judged.' Dr. Peter Piot, the director of the U.N. AIDS program, a partner in the 3 by 5 effort, said, 'We have to be frank and admit that we have a long way to go.'
PROQUEST:661770371
ISSN: n/a
CID: 81965

Aids [Newspaper Article]

Altman, Lawrence K
As the 15th International AIDS Conference starts today in Bangkok, few expect the 15,000 participants will learn about a cure or successful vaccine
PROQUEST:661379661
ISSN: 0362-4331
CID: 81963

WHO lagging behind HIV treatment goal / Officials insist therapy will reach 3 million by 2005 [Newspaper Article]

Altman, Lawrence K
Falling short: In its first progress report, issued a day before the 15th International AIDS Conference in Bangkok, Thailand, today, the World Health Organization estimated that 440,000 people were being treated. That is about twice as many as in 2002, said Dr. Jim Kim, director of the agency's AIDS program. But the agency's goal had been to treat 60,000 more people by now. Only Botswana, Indonesia and Uganda have published such plans. Botswana is treating 18,000 people, with a goal of 30,000; Indonesia is treating 1,500, with a goal of 3,500; and Uganda is treating 20,000, with a goal of 55,000, said Melanie Zipperer, an agency spokeswoman
PROQUEST:661477621
ISSN: 1074-7109
CID: 81962

Goal for HIV treatment still possible, WHO says [Newspaper Article]

Altman, Lawrence K
In its first progress report, issued a day before the 15th International AIDS Conference here today, the WHO estimated that 440,000 people were being treated. That is about twice as many as in 2002, said Dr. Jim Kim, director of the agency's AIDS program. But the agency's goal had been to treat 60,000 more people by now. [Lee Jong Wook] said that the U.N. agency could not let it fail because 'the collective response to the HIV/AIDS pandemic is the benchmark by which our generation will be judged.' Only Botswana, Indonesia and Uganda have published such plans. Botswana is treating 18,000 people, with a goal of 30,000; Indonesia is treating 1,500, with a goal of 3,500; and Uganda is treating 20,000, with a goal of 55,000, said Melanie Zipperer, an agency spokeswoman. -->
PROQUEST:661432301
ISSN: 0745-4724
CID: 81961

As bird flu persists, a race for a vaccine Fearing pandemic, nations stock drugs [Newspaper Article]

Bradsher, Keith; Altman, Lawrence K
China is negotiating to buy its own supply of Tamiflu, a senior Chinese health official said in an interview. Taiwan has already bought a large stockpile of Tamiflu, and is seeking to buy more and to set up its own production facilities. In Japan, the Health Ministry is also trying to arrange for domestic production of Tamiflu, which is now made at a single factory in Europe by the drug company Roche Holding. Tamiflu, an antiviral, is only effective if given in the first two days after the onset of infection. Since many people with little more than the sniffles would take Tamiflu before it became clear they did not actually have bird flu, the amount of Tamiflu needed in a health emergency could be enormous, said Roy Anderson, an epidemiologist at the University of London. Tamiflu is a fairly new drug, still under patent and very costly. Its typical retail cost in the United States is $68 for a 10- capsule treatment to be taken over five days. 'If Tamiflu is to be used in a pandemic situation, it will have to be stockpiled,' a Roche official said, warning that, 'it takes time to produce mass quantities.'
PROQUEST:661423101
ISSN: 0294-8052
CID: 81966

Countries racing to head off pandemic of avian influenza [Newspaper Article]

Bradsher, Keith; Altman, Lawrence K
Even before China, Thailand and Vietnam reported new outbreaks in chickens in the last few days, governments in bigger and more affluent countries were preparing for a possible pandemic among humans. The United States and European nations are trying to buy stockpiles of Tamiflu, the only drug believed to be effective for people infected with the A(H5N1) strain of bird flu, and they are racing to develop an effective vaccine
PROQUEST:661423201
ISSN: 0294-8052
CID: 81967

As Bird Flu Persists, Global Leaders Prepare for the Worst [Newspaper Article]

Bradsher, Keith; Altman, Lawrence K
Even before China, Thailand and Vietnam reported new outbreaks in chickens in the last few days, governments in bigger and more affluent countries were preparing for a possible pandemic among humans. The United States and European nations have been negotiating to buy stockpiles of Tamiflu, the only drug believed effective for people infected with the A(H5N1) strain of bird flu, and they have been racing to develop an effective vaccine. China is negotiating to buy its own supply of Tamiflu, a senior Chinese health official said in an interview. Taiwan has already bought a large stockpile of Tamiflu, and is seeking to buy more and to set up its own production facilities. In Japan, the Health Ministry is also trying to arrange for domestic production of Tamiflu, which is now made at a single factory in Europe by the drug company Roche Holding. Health experts say that these preparations may not go far enough. Tamiflu, an antiviral, is only effective if given in the first two days after the onset of infection. Since many people with little more than the sniffles would take Tamiflu before it became clear they did not actually have bird flu, the amount of Tamiflu needed in a health emergency could be enormous, said Dr. Roy Anderson, an epidemiologist at the University of London. Tamiflu is a fairly new drug, still under patent and very costly. Its typical retail cost in the United States is $68 for a 10-capsule treatment to be taken over five days. Although Roche sells it for less at wholesale, it is expensive to stockpile and difficult to manufacture
PROQUEST:660611751
ISSN: 0362-4331
CID: 81970